García-Pagán JC - Search Results

1

Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.

Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J. Bañares R, et al. Hepatology. 1999 Jul;30(1):79-83. doi: 10.1002/hep.510300124. Hepatology. 1999. PMID: 10385642 Clinical Trial.

2

Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.

García-Pagán JC, Navasa M, Rivera F, Bosch J, Rodés J. García-Pagán JC, et al. Gastroenterology. 1992 Jun;102(6):2015-23. doi: 10.1016/0016-5085(92)90327-u. Gastroenterology. 1992. PMID: 1316859

3

Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.

Bosch J, Pizcueta MP, Fernández M, Feu F, Cirera I, Luca A, García-Pagán JC. Bosch J, et al. Baillieres Clin Gastroenterol. 1992 Sep;6(3):425-36. doi: 10.1016/0950-3528(92)90030-i. Baillieres Clin Gastroenterol. 1992. PMID: 1421593 Review.

4

Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.

Panés J, Bordas JM, Piqué JM, Bosch J, García-Pagán JC, Feu F, Casadevall M, Terés J, Rodés J. Panés J, et al. Gastroenterology. 1992 Dec;103(6):1875-82. doi: 10.1016/0016-5085(92)91447-c. Gastroenterology. 1992. PMID: 1451980

5

Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.

Lacy AM, Navasa M, Gilabert R, Brú C, García-Pagán JC, García-Valdecasas JC, Grande L, Feu F, Fuster J, Terés J, et al. Lacy AM, et al. Hepatology. 1992 Apr;15(4):616-22. doi: 10.1002/hep.1840150411. Hepatology. 1992. PMID: 1551639

6

[Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].

Navasa M, García-Pagán JC, Bosch J, Rodés J. Navasa M, et al. Med Clin (Barc). 1992 Feb 29;98(8):290-4. Med Clin (Barc). 1992. PMID: 1560714 Spanish.

7

Pathophysiology of portal hypertension.

Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Bosch J, et al. Gastroenterol Clin North Am. 1992 Mar;21(1):1-14. Gastroenterol Clin North Am. 1992. PMID: 1568769 Review.

8

Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.

La Villa G, Salmerón JM, Arroyo V, Bosch J, Ginés P, García-Pagán JC, Ginés A, Asbert M, Jiménez W, Rivera F, et al. La Villa G, et al. Gastroenterology. 1992 Jun;102(6):2114-9. doi: 10.1016/0016-5085(92)90340-5. Gastroenterology. 1992. PMID: 1587432

9

Portal hypertension in acute liver failure.

Navasa M, Garcia-Pagán JC, Bosch J, Riera JR, Bañares R, Mas A, Bruguera M, Rodés J. Navasa M, et al. Gut. 1992 Jul;33(7):965-8. doi: 10.1136/gut.33.7.965. Gut. 1992. PMID: 1644339 Free PMC article.

10

Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Pizcueta MP, et al. Gastroenterology. 1991 Dec;101(6):1710-5. doi: 10.1016/0016-5085(91)90411-d. Gastroenterology. 1991. PMID: 1683327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters